National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

incyclinide
A chemically-modified tetracycline with potential antineoplastic activity. Incyclinide inhibits matrix metalloproteinases (MMPs), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. This agent also causes mitochondrial depolarization in tumor cells and induces both cellular apoptosis and tissue necrosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Metastat
Code names:CMT-3
COL 3
Chemical structure names:
  • 4-dimethlyamino sancycline
  • 4-dimethlyaminosancycline
  • 6-deoxy, 6-demethyl, 4-de-dimethylamino tetracycline



Previous:Imuran, inalimarev, Inapsine, Incel, incomplete Freund's adjuvant
Next:indibulin, indicine-N-oxide, indinavir sulfate, indium I 111 bevacizumab, indium I 111 chimeric monoclonal antibody G250

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov